14.03.2024 - andera Life Sciences - Press releases

Andera Partners’ portfolio company Tubulis closes upsized €128 Million Series B2 to accelerate the d…

Combined Shape

14.03.2024 - andera Life Sciences - Press releases

Amolyt Pharma, an Andera Partners’ portfolio company, announces its sale to AstraZeneca

Combined Shape

28.02.2024 - andera Infra - Press releases

Andera Partners raises a final amount of € 233 million for Andera Smart Infra 1, its first fund dedi…

Combined Shape

21.02.2024 - andera Life Sciences - Press releases

MMI Raises $110 Million in Series C Financing

Combined Shape

12.02.2024 - andera Life Sciences - Recruitment

Internship Offer – Andera Life Sciences

12.02.2024 - Andera Partners - Press releases

2023 Report – After a record year of investments and exits, Andera Partners sets a target of 7…

Combined Shape

24.01.2024 - andera Expansion/Croissance - Press releases

Meogroup initiates a new development cycle with the support of Andera Partners

Combined Shape

23.01.2024 - Andera Partners - Press releases

Andera Partners welcomes Sophie ELKRIEF as Business Development Partner

Combined Shape

18.01.2024 - andera MidCap - Press releases

Mistertemp’ group announces the reorganization of its shareholding: Andera Partners succeeds Montefi…

Combined Shape

21.12.2023 - andera Infra - Press releases

Spanish energy transition developer INGENOSTRUM accelerates, with a fund raising of 25M€ from Andera…

Combined Shape

14.12.2023 - andera Acto - Press releases

The Efor Group joins forces with the Nodarius Group, which includes the Altogen brand, to strengthen…

Combined Shape

05.12.2023 - andera Acto - Press releases

The Imagerie Cardinet Group strengthens its position to accelerate its entrepreneurial model

Combined Shape

30.11.2023 - andera Infra - News Infra - Press releases

mylight150 secures €100m to accelerate the expansion of its solar self-consumption & smart ener…

Combined Shape

14.11.2023 - andera Life Sciences - Press releases

Andera Partners co-leads a €67.5 million ($72 million) oversubscribed Series C round for cancer immu…

Combined Shape

13.11.2023 - andera Acto - Press releases

Andera Partners joins forces with Founders of Gosto Group in providing support in their internationa…

Combined Shape

27.10.2023 - andera Life Sciences - Press releases

JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy E…

Combined Shape

11.10.2023 - andera Life Sciences - Press releases

Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline

Combined Shape

10.10.2023 - andera Expansion/Croissance - Press releases

ELAN Languages acquires Dutch company AVB Vertalingen

Combined Shape

05.10.2023 - andera Life Sciences - Press releases

Agomab Receives FDA Fast Track Designation for AGMB-129 in Fibrostenosing Crohn’s Disease and Starts…

Combined Shape

05.10.2023 - andera Acto - Press releases

Andera Acto supports EFOR’s ambition of becoming a global leader in its market within five yea…

Combined Shape

04.10.2023 - andera Acto - Press releases

Andera Partners completes full exit from Travelsoft Group and hands over to CAPZA

Combined Shape

18.09.2023 - andera MidCap - Press releases

Andera Partners increases the hard cap for Andera MidCap 5 and raises a final amount of €750 million

Combined Shape

24.07.2023 - andera Life Sciences - Press releases

Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumo…

Combined Shape

11.07.2023 - Andera Partners - Sustainability - Publications

2022 Sustainability Report

Combined Shape

06.07.2023 - andera MidCap - Press releases

PAI Partners to acquire majority stake in Infra Group

Combined Shape

04.07.2023 - andera Expansion/Croissance - Press releases

ELAN Languages completes acquisition of German group Lingua-World GmbH

Combined Shape

29.06.2023 - andera Acto - Press releases

Andera Acto supports Auris Group in restructuring of its capital and in its development strategy

Combined Shape

27.06.2023 - andera Life Sciences - Press releases

Allecra Therapeutics Submits New Drug Application to the U.S. FDA for EXBLIFEP® for the Treatment of…

Combined Shape

19.06.2023 - andera Acto - Press releases

Siparex ETI finalises agreement to become majority shareholder of Passman group

Combined Shape

14.06.2023 - andera MidCap - Press releases

Andera Partners and Pauwels Consulting management team join forces to accelerate the development of…

Combined Shape

01.06.2023 - andera Life Sciences - Press releases

Inotrem announces publication of two key articles on nangibotide Phase II programs in peer-reviewed…

Combined Shape

15.05.2023 - andera Life Sciences - Press releases

Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg t…

Combined Shape

10.05.2023 - Andera Partners - Press releases

Andera Partners appoints Stefan Keitel Senior Advisor DACH region further strengthening its presence…

Combined Shape

25.04.2023 - andera Acto - Press releases

OneXillium group partners with Andera Acto to support them in their next development cycle

Combined Shape

20.04.2023 - andera Life Sciences - Press releases

Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation A…

Combined Shape

18.04.2023 - andera Life Sciences - Press releases

Andera Partners co-leads a Series A extension round of € 47.75 million for radiopharmaceutical compa…

Combined Shape

13.04.2023 - andera Life Sciences - Press releases

Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix®

Combined Shape

05.04.2023 - andera Acto - Press releases

BEA Group (Andera Acto) expands in Italy, through acquisition of Capanna

Combined Shape

29.03.2023 - andera Life Sciences - Press releases

Grey Wolf Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GRWD5769 in…

Combined Shape

22.03.2023 - andera Acto - Press releases

Andera Acto supports SPS Group, a member of the ECF network, in its capital restructuring

Combined Shape

15.03.2023 - andera Life Sciences - Press releases

Andera Partners co-leads $25m extension round for FIRE1

Combined Shape

15.03.2023 - andera Acto - Press releases

NG Travel Group chooses Andera Acto to support them in their capital restructuring

Combined Shape

03.03.2023 - andera Life Sciences - Press releases

Flamingo Therapeutics and Dynacure Announce Merger to Create Leading RNA Therapeutics Company Focuse…

Combined Shape

01.03.2023 - andera Acto - Press releases

Redslim partners with Andera Acto to support them in their next development cycle

Combined Shape

16.02.2023 - Andera Partners - Press releases

2022 Report – Andera Partners

Combined Shape

13.02.2023 - andera Life Sciences - Press releases

Andera Partners Portfolio Company Mineralys Therapeutics Successfully Completes Upsized $192 Million…

Combined Shape

02.02.2023 - andera Life Sciences - Press releases

Agomab Reports Positive Phase 1 Results with AGMB-129, a GI-restricted ALK5 Inhibitor for Fibrosteno…

Combined Shape

26.01.2023 - andera Life Sciences - Press releases

Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics

Combined Shape

23.01.2023 - andera MidCap - Press releases

Andera Partners reaches its €600 million target for Andera MidCap 5

Combined Shape

10.01.2023 - andera Life Sciences - Press releases

Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatmen…

Combined Shape

09.01.2023 - andera Life Sciences - Press releases

Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma

Combined Shape

14.12.2022 - andera MidCap - Andera Partners - Press releases

Andera Partners opens its Milan office

Combined Shape

25.10.2022 - andera MidCap - Press releases

KLUBB Group acquires Isoli S.p.A.

Combined Shape

20.10.2022 - andera Life Sciences - Press releases

T-knife Therapeutics Announces Dosing of First Patient with TK-8001 in the IMAG1NE Phase 1/2 Clinica…

Combined Shape

13.10.2022 - andera MidCap - Press releases

Andera Partners invests in a high-performance detection solutions company Senstronic

Combined Shape

10.10.2022 - Andera Partners - Press releases

New governance for Andera Partners

Combined Shape

10.10.2022 - andera Life Sciences - Press releases

Andera Partners raises its largest life sciences fund at €456M, demonstrating the attractiveness of…

Combined Shape

04.10.2022 - andera Acto - Press releases

Ozitem chooses Andera Acto to support them in their capital restructuring

Combined Shape

03.10.2022 - andera Life Sciences - Press releases

Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic…

Combined Shape

16.09.2022 - andera Life Sciences - Press releases

JenaValve Completes Enrollment in the ALIGN-ARIDE Clinical Trial

Combined Shape

15.09.2022 - andera Life Sciences - Press releases

TRiCares Raises €47m in a First Closing of its Series C

Combined Shape

12.09.2022 - andera Life Sciences - Press releases

Agomab Therapeutics Selected as One of Fierce Biotech’s “Fierce 15” Companies of 2…

Combined Shape

30.08.2022 - andera Infra - News Infra - Publications

French electric vehicle charging points market

Combined Shape

30.08.2022 - andera Infra - News Infra - Publications

Maritim Mobility

Combined Shape

30.08.2022 - andera Infra - News Infra - Publications

Datacenters

Combined Shape

30.08.2022 - andera Infra - News Infra - Publications

Heat, the forsaken vector of a renewable future

Combined Shape

30.08.2022 - andera Infra - News Infra - Publications

Green hydrogen will fuel tomorrow’s economy

Combined Shape

20.07.2022 - andera Life Sciences - Press releases

Medical Microinstruments Secures $75M to Advance Robotic Microsurgery

Combined Shape

13.07.2022 - andera Life Sciences - Press releases

Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114M

Combined Shape

07.07.2022 - andera Life Sciences - Press releases

Andera Partners strengthens its Life Sciences team with a new partner

Combined Shape

04.07.2022 - Sustainability - Publications

Annual CSR Report 2021 / Rapport Annuel RSE 2021

Combined Shape

13.06.2022 - andera Life Sciences - Press releases

ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Validation of…

Combined Shape

08.06.2022 - andera Life Sciences - Press releases

Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to…

Combined Shape

17.05.2022 - andera Life Sciences - Press releases

TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replace…

Combined Shape

13.05.2022 - andera MidCap - Press releases

Andera Partners announces the intermediate closing of its new fund Andera MidCap 5 at €450m

Combined Shape

11.05.2022 - andera MidCap - Press releases

HR Path receives €225 million in Financing

Combined Shape

03.05.2022 - andera Life Sciences - Press releases

Andera Partners leads Tubulis’ €60 million Series B financing to advance its development of novel AD…

Combined Shape

27.04.2022 - andera Expansion/Croissance - Press releases

Andera Partners to support ElaN Group, the leading technology platform for translation services in t…

Combined Shape

26.04.2022 - andera Life Sciences - Press releases

Successful first in human implantation of Topaz Tricuspid Heart Valve Replacement System

Combined Shape

07.04.2022 - andera Life Sciences - Press releases

Andera Partners to sell its Life Sciences’ portfolio company ReViral to Pfizer

Combined Shape

01.04.2022 - andera Co-Invest - Press releases

Andera Partners and Compagnie Lebon launch a co-investment activity

Combined Shape

31.03.2022 - Andera Partners - Press releases

Andera Partners announces two promotions to Partner and several appointments to strengthen its teams

Combined Shape

22.03.2022 - andera Life Sciences - Press releases

Evommune Initiates Phase 1 Study to Evaluate Safety of EVO101, an IRAK4 Inhibitor, in Healthy Volunt…

Combined Shape

24.02.2022 - Andera Partners - Press releases

Andera Partners creates Andera Partners Transformation A unique support platform in private equity i…

Combined Shape

22.02.2022 - andera Life Sciences - Press releases

Andera Partners supports TargED Biopharmaceuticals in €39 million Series A financing to bring ground…

Combined Shape

17.02.2022 - Andera Partners - Press releases

With nearly €550 million deployed, Andera Partners experienced a record year in 2021

Combined Shape

03.02.2022 - andera Infra - Press releases

Andera Partners invests in green renewable hydrogen production company Lhyfe

Combined Shape

19.01.2022 - andera Life Sciences - Press releases

JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited

Combined Shape

13.01.2022 - andera Life Sciences - Press releases

Allecra Therapeutics and ADVANZ PHARMA Sign Exclusive License and Supply Agreement for Allecra’s Ant…

Combined Shape

10.01.2022 - andera Life Sciences - Press releases

BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision i…

Combined Shape

09.12.2021 - andera Infra - Press releases

Andera Partners announces 1st closing at €84m for Andera Smart Infra 1

Combined Shape

22.11.2021 - andera Life Sciences - Press releases

Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology

Combined Shape

15.11.2021 - andera Acto - Press releases

Andera Partners supports the Founder of ENACO Group in the acquisition of its entire share capital a…

Combined Shape

28.10.2021 - andera Life Sciences - Press releases

Agomab Therapeutics to Acquire Origo Biopharma

Combined Shape

26.10.2021 - andera Life Sciences - Press releases

Andera Partners supports Exciva in a Series A to fight Alzheimer’s disease

Combined Shape

29.09.2021 - Andera Partners - Publications

The role of private equity in the recovery in France and Europe: an opportunity for investors

Combined Shape

16.09.2021 - andera Life Sciences - Press releases

Andera Partners leads Amolyt Pharma’s $80 million Series B alongside Sectoral Asset Management

Combined Shape

10.09.2021 - andera Acto - Press releases

Andera Acto supports DP Software Group in its development strategy

Combined Shape

09.09.2021 - andera Life Sciences - Press releases

Andera Partners leads US$ 83 million series A round in Evommune Inc. for the development of transfor…

Combined Shape

08.09.2021 - Andera Partners - Press releases

Andera Partners strengthens its investment teams and reaffirms its growth ambition

Combined Shape

02.08.2021 - andera Life Sciences - Press releases

T-knife Announces $110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies

Combined Shape

27.07.2021 - andera Life Sciences - Press releases

Artios Pharma has completed a $153 million series C

Combined Shape

26.07.2021 - andera MidCap - Press releases

Andera Partners and the KLUBB Group’s founder join forces

Combined Shape

23.07.2021 - Sustainability - Press releases

Andera Partners publishes its first Climate & Sustainability Report

Combined Shape

22.07.2021 - andera Expansion/Croissance - Press releases

Andera Expansion acquires MC2 Technologies

Combined Shape

08.07.2021 - andera MidCap - Press releases

Andera Partners sells its majority stake in Infra Group

Combined Shape

06.07.2021 - andera MidCap - Press releases

Andera MidCap sells its stake in Minafin

Combined Shape

05.07.2021 - andera Life Sciences - Press releases

TRiCares announces the successful first in human implantations of “Topaz”

Combined Shape

23.06.2021 - andera Life Sciences - Press releases

Poxel announces the approval of Twymeeg

Combined Shape

18.06.2021 - andera MidCap - Press releases

Andera sells its stake in Netco Group

Combined Shape

04.05.2021 - andera Life Sciences - Press releases

Life Sciences portfolio company Gamamabs signs an agreement with Exelixis

Combined Shape

27.04.2021 - andera Life Sciences - Andera Partners - Press releases

Andera Partners strengthens its presence in the DACH region

Combined Shape

13.04.2021 - andera Infra

Internship offer – Infrastructure investment

07.04.2021 - andera Life Sciences

Artios Pharma announces collaboration with Novartis

06.04.2021 - Andera Partners - Press releases

Andera creates its own foundation

Combined Shape

09.03.2021 - Andera Partners - Press releases

Andera Partners announces the arrival of Noëlla de Bermingham as Chief Sustainability Officer

Combined Shape

02.03.2021 - andera Life Sciences - Press releases

ReViral and LianBio Announce Exclusive Collaboration

Combined Shape

26.02.2021 - andera MidCap - Press releases

Pusterla 1880 issues Sustainability-Linked Bonds to finance its growth

Combined Shape

16.02.2021 - andera Infra - Andera Partners - Press releases

Our 5th area of activity: Andera Infra

Combined Shape

10.02.2021 - andera Life Sciences - Press releases

MedLumics closes upsized EUR 18M financing round and appoints new Chairman

Combined Shape

05.02.2021 - Andera Partners - Press releases

Andera strengthens governance and targets €4-5 billion in AUM by 2025

Combined Shape

04.02.2021 - andera MidCap - Press releases

Andera MidCap sells Skill & You to IK Investment Partners

Combined Shape

13.01.2021 - andera Life Sciences

MMI appoints healthcare industry veteran Mark Toland as CEO

12.01.2021 - andera MidCap - Press releases

Andera MidCap invests in Pusterla 1880

Combined Shape

07.01.2021 - andera Life Sciences - Press releases

AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial

Combined Shape

05.01.2021 - andera Life Sciences - Press releases

Andera sells its Life Sciences’ portfolio company Arvelle Therapeutics

Combined Shape

04.01.2021 - andera Life Sciences - Press releases

Inotrem’s COVID-19 Phase IIa Clinical Trial declared “National Priority Research” by the French gove…

Combined Shape

21.12.2020 - Uncategorized - Press releases

Significant agreements with Chinese market leaders in our Life Sciences portfolio

Combined Shape

01.12.2020 - Andera Partners - Press releases

Andera Partners renames all its activities

Combined Shape

21.10.2020 - Andera Partners - Press releases

The Power of And

Combined Shape

12.10.2020 - andera Life Sciences - Press releases

Medlumics lands a 14M€ new financing round

Combined Shape

28.08.2020 - andera Life Sciences - Press releases

Reviral raises $44 million in Series C financing

Combined Shape

06.08.2020 - andera Life Sciences - Press releases

T-knife completes €66m Series A financing

Combined Shape

23.07.2020 - andera Life Sciences - Press reviews

COVID-19: assessing nangibotide in mechanically ventilated patients with COVID-19

Combined Shape

29.06.2020 - andera Acto - Press releases

ActoMezz IV: a single closing at more than €500 million

Combined Shape

11.06.2020 - andera Life Sciences - Press releases

BioDiscovery sells Corvidia to Novo Nordisk

Combined Shape

06.05.2020 - andera Life Sciences - Press releases

Appointment of Michael H. Carrel as chairman of the Axonics board of directors.

Combined Shape

06.05.2020 - andera Life Sciences - Press releases

 Axonics Modulation Technologies reports financial results for the 1st quarter 2020 and provides an…

Combined Shape

02.04.2020 - andera Life Sciences - Press releases

Dynacure Announces €50M ($55M) Series C Financing

Combined Shape

01.04.2020 - andera Life Sciences - Press releases

AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI

Combined Shape

05.03.2020 - Andera Partners - Publications

Newsletter – 03/2020

Combined Shape

28.02.2020 - andera Life Sciences - Press releases

Allecra Therapeutics announces positive top-Line results for phase 3 ALLIUM clinical trial of EXBLIF…

Combined Shape

27.02.2020 - Andera Partners - Press releases

2019: a new record year for Andera

Combined Shape

21.11.2019 - andera Life Sciences - Press releases

Inotrem Announces Enrollment of First Patient in its Phase IIb Trial in the Treatment of Septic Shoc…

Combined Shape

14.10.2019 - andera Expansion/Croissance - Press releases

Hans Van de Velde – Senior Advisor Belgium

Combined Shape

11.10.2019 - andera Life Sciences - Press releases

BioDiscovery invests in AgomAb Therapeutics

Combined Shape

16.07.2019 - andera Life Sciences - Press releases

BioDiscovery co-leads $133 million Financing in AM-Pharma B.V.

Combined Shape

02.07.2019 - andera Expansion/Croissance - Press releases

The ORCA Group acquires Italian companies Angeloni and Impregnatex

Combined Shape

01.07.2019 - Andera Partners - Publications

ic20: Initiative Climate 2020

Combined Shape

15.05.2019 - andera MidCap - Press releases

Winch invests in Spherea

Combined Shape

05.04.2019 - andera MidCap - Press releases

Winch invests in the Belgian company Infra Group

Combined Shape

03.04.2019 - andera Acto - Press releases

ActoMezz invests in Tournus

Combined Shape

28.03.2019 - Andera Partners - Press releases

Appointments and Recruitments

Combined Shape

14.02.2019 - andera Life Sciences - Press releases

A syndicate of international investors finance Arvelle Therapeutics

Combined Shape

11.02.2019 - andera Life Sciences - Press releases

Grey Wolf Therapeutics completes £10 million series A financing with Andera Partners and Canaan

Combined Shape

28.01.2019 - andera MidCap - Press releases

NetCo welcomes IK among its shareholders, alongside Andera and the founding family

Combined Shape

18.01.2019 - Andera Partners - Press releases

2018: an emblematic year for Andera Partners

Combined Shape

03.12.2018 - andera MidCap - Press releases

Winch Capital 4: fundraising completed at €445 million

Combined Shape

05.11.2018 - andera Life Sciences - Press releases

Crescendo Biologics announces early licensing by Takeda

Combined Shape

05.11.2018 - andera Life Sciences - Press releases

Promising results for the lead program of Genkyotex (BioDiscovery 3) in a fibrotic orphan disease

Combined Shape

02.08.2018 - andera Life Sciences - Press releases

Artios Pharma Announces $86 million (£65 million) Series B Financing

Combined Shape

18.07.2018 - andera MidCap - Press releases

WINCH Capital 4: a first closing of €360m for Andera Partners mid-cap fund

Combined Shape

06.07.2018 - andera Life Sciences - Press releases

BioDiscovery invests in Dynacure to advance lead program into clinical development

Combined Shape

04.07.2018 - Andera Partners - Press releases

Renewed governance for Andera Partners

Combined Shape

04.06.2018 - andera Life Sciences - Press releases

ENYO Pharma raises €40 million in Series B fundraising

Combined Shape

04.06.2018 - andera Life Sciences - Press releases

TRiCares Closes €22 Million ($25.4 Million) Series B Financing Round to Fund Development of Minimall…

Combined Shape

22.05.2018 - andera Life Sciences - Press releases

GamaMabs Pharma to present at 2018 ASCO annual meeting results from the First-In-Human clinical stud…

Combined Shape

02.05.2018 - andera Life Sciences - Press releases

Crescendo Biologics Ltd. raises $70 Million (€57 Million) in Series B financing

Combined Shape

26.04.2018 - andera MidCap - Press releases

Andera Partners sponsors the carve-out of Conduent’s Off-Street Parking business in association with…

Combined Shape

25.04.2018 - andera Life Sciences - Press releases

Corvidia Therapeutics Secures $60 Million in Series B Funding

Combined Shape

04.04.2018 - Andera Partners - Press releases

EdRIP becomes ANDERA PARTNERS

Combined Shape
Sorry, no results.